 Pirenzepine
"Pirenzepine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Descriptor ID |
D010890
|
| MeSH Number(s) |
D03.438.079.080.070.750
|
| Concept/Terms |
Pirenzepin-ratiopharm- Pirenzepin-ratiopharm
- Pirenzepin ratiopharm
- ratiopharm Brand of Pirenzepine Dihydrochloride
Ulcoprotect- Ulcoprotect
- Azupharma Brand of Pirenzepine Dihydrochloride
Ulgescum- Ulgescum
- Dolorgiet Brand of Pirenzepine Dihydrochloride
Piren-basan- Piren-basan
- Piren basan
- Sagitta Brand of Pirenzepine Dihydrochloride
pirenzepin von ct- pirenzepin von ct
- ct-Arzneimittel Brand of Pirenzepine Dihydrochloride
Gastrozepin- Gastrozepin
- Boehringer Ingelheim Brand of Pirenzepine Dihydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Pirenzepine".
Below are MeSH descriptors whose meaning is more specific than "Pirenzepine".
This graph shows the total number of publications written about "Pirenzepine" by people in this website by year, and whether "Pirenzepine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1993 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pirenzepine" by people in Profiles.
-
Pediani JD, Ward RJ, Godin AG, Marsango S, Milligan G. Dynamic Regulation of Quaternary Organization of the M1 Muscarinic Receptor by Subtype-selective Antagonist Drugs. J Biol Chem. 2016 Jun 17; 291(25):13132-46.
-
Pedretti RF, Prete G, Foreman RD, Adamson PB, Vanoli E. Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. J Cardiovasc Pharmacol. 2003 May; 41(5):671-7.
-
Grant JE. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report. J Clin Psychiatry. 2001 Apr; 62(4):297-8.
-
Mitchell RW, Halayko AJ, Kahraman S, Solway J, Wylam ME. Selective restoration of calcium coupling to muscarinic M(3) receptors in contractile cultured airway myocytes. . 2000 May; 278(5):L1091-100.
-
Finkel SI. Managing the behavioral and psychological signs and symptoms of dementia. Int Clin Psychopharmacol. 1997 Sep; 12 Suppl 4:S25-8.
-
Khare S, Tien XY, Wilson D, Wali RK, Bissonnette BM, Sitrin MD, Brasitus TA. Vitamin D status modulates rat colonic M3 muscarinic receptor characteristics and coupling to guanylate cyclase. FEBS Lett. 1994 Jun 20; 347(1):27-30.
-
Mitchell RW, Koenig SM, Popovich KJ, Kelly E, Tallet J, Leff AR. Pertussis toxin augments beta-adrenergic relaxation of muscarinic contraction in canine trachealis. Am Rev Respir Dis. 1993 Feb; 147(2):327-31.
-
El-Sabbagh HN, Bloom SR, Adrian TE, Prinz RA, Baron JH, Welbourn RB. The effect of pirenzepine on meal-stimulated gastrointestinal hormones. Scand J Gastroenterol Suppl. 1980; 66:57-61.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|